Vigilant Biosciences® sviluppa metodi avanzati e accurati per facilitare il rilevamento precoce del tumore orale identificando diversi biomarcatori unici che si sono dimostrati associati al tumore orale. Scopra come questa tecnologia salvavita può fare la differenza per i suoi pazienti.® is proud to partner with the teams at Novalis Life Sciences, venVelo, White Owl Ventures, and the Florida Institute for the Commercialization of Public Research.
Novalis LifeSciences LLC is an investment and advisory firm for the Life Science industry. Novalis was founded in 2017 by Marijn E. Dekkers and invests in small to medium size, innovative Life Science companies.
venVelo, the premier early-stage venture fund in Florida for innovative companies seeking capital and mentoring, was launched in 2012 and quickly established itself as one of the most active venture funds in central Florida. It was named the 2014 “Tech Investor of the Year”. In addition to its investments, venVelo board members have been frequent speakers, panelists, and venture competition judges around the state. venVelo also has donated money to a variety of organizations working to develop the central Florida entrepreneurial ecosystem.
White Owl Capital Partners is a New York City based private investment firm focused on finding exceptional entrepreneurs and providing the capital and advice to help them build great companies. White Owl’s investments span several industries (tech, healthcare, media, banking, logistics, and energy) and geographic regions (US, Canada, UK, Russia, China).
Formed by the Florida Legislature in 2007, the Florida Institute for the Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions. Together, these entities leverage a $2B+ research base and form investable companies that create clean jobs in new industries driving the global economy.